financetom
Business
financetom
/
Business
/
Cash sweep scrutiny threatens wealth managers' credit ratings, Moody's says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cash sweep scrutiny threatens wealth managers' credit ratings, Moody's says
Aug 16, 2024 4:17 AM

(Reuters) - The spate of regulatory investigations into wealth managers' cash sweep programs could hurt their credit ratings, Moody's warned on Thursday, underscoring the threat to the high-margin business for firms like Morgan Stanley ( MS ) and Wells Fargo ( WFC ).

WHY IT'S IMPORTANT

A potential ratings downgrade would increase the costs for wealth managers at a time when worries about the economy are growing, with some forecasting a downturn due to the tight monetary policy.

CONTEXT

Cash sweep programs allow wealth managers to move un-invested cash in brokerage accounts to partner banks, enabling clients to earn returns on idle funds.

However, these arrangements have led to disputes, as the interest paid by partner banks is typically lower than what customers could earn through other options, such as money market funds.

To prevent these conflicts, wealth managers have started giving clients more choices. Customers can opt to park their un-invested money in tax-exempt funds or other vehicles instead of moving it to their brokers' partner banks.

Morgan Stanley ( MS ), Wells Fargo ( WFC ) and Bank of America have also raised the interest rates they pay on some brokerage accounts.

Despite these efforts, regulatory investigations remain a concern. Wells Fargo ( WFC ) and Morgan Stanley ( MS ) have disclosed their cash sweep programs are under review from the SEC, while Bank of America highlighted it as a potential risk factor in its quarterly filing.

Moody's said that having multiple revenue streams will help mitigate the risk for larger firms. However, private-equity owned wealth managers with high debt burdens and less diversified business models are likely to be more severely affected.

The investigations could squeeze margins across the industry by prompting firms to increase the interest on brokerage accounts, the ratings agency added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US working 'as fast as we can' to finalize EV conversion grants, official says
US working 'as fast as we can' to finalize EV conversion grants, official says
Oct 22, 2024
* DOE announced $1.7 billion in grants for EV plant conversions * UAW threatens strikes over Stellantis ( STLA ) delays in Belvidere investment * Granholm emphasizes Biden administration's commitment to EV production By David Shepardson, Nora Eckert DETROIT, Oct 22 (Reuters) - U.S. Energy Secretary Jennifer Granholm said Tuesday the department is working as fast as we can to...
Sangamo Therapeutics Shares Surge After US FDA Clears Potential Fabry Disease Treatment for Expedited Review
Sangamo Therapeutics Shares Surge After US FDA Clears Potential Fabry Disease Treatment for Expedited Review
Oct 22, 2024
11:10 AM EDT, 10/22/2024 (MT Newswires) -- Sangamo Therapeutics ( SGMO ) shares surged past 31% in recent Tuesday trading after the genomic medicine company said the US Food and Drug Administration has laid out a clear pathway for accelerated approval for its ST-920 gene therapy candidate for the treatment of Fabry disease. Fabry disease is a genetic condition characterized...
Hesai Technology to Exclusively Provide Lidar for New Leapmotor Models
Hesai Technology to Exclusively Provide Lidar for New Leapmotor Models
Oct 22, 2024
11:13 AM EDT, 10/22/2024 (MT Newswires) -- Hesai Technology said Tuesday it will exclusively supply long-range lidar for Leapmotor's new models, with the first model slated for mass production in 2025. Under the agreement, Hesai ( HSAI ) said it will provide lidar systems for multiple upcoming models, expanding the companies' collaboration on intelligent driving systems. Hesai ( HSAI )...
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
Oct 22, 2024
Quest Diagnostics Inc posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26. Sales increased 8.5% year-over-year to $2.49 billion, beating the consensus of $2.42 billion. Quest Diagnostics ( DGX ) saw total revenue growth of 8.5%, including 4.2% organic growth, said Quest Diagnostics CEO Jim Davis. “Our performance was driven by new customer wins and expanded business with physicians...
Copyright 2023-2026 - www.financetom.com All Rights Reserved